AbbVie - Quarterly Earnings & Financial data

Income Statement (NONE)

Balance Sheet (NONE)

Cash Flow (NONE)

EPS

Financial Highlights for AbbVie in Q4 '25

AbbVie reported a revenue of 16.6B, which is a 5.3% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.

Gross Profit stood at 14B, marking a 33.3% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.

Cost of Revenue was 2.66B, a -49.9% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.

Operating Expenses for this period were 8.15B, showing a -4.8% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.

Net Income for the quarter was 1.82B, showing a 876.3% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.

The company's EBITDA for the quarter was 16B, showing a 356% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.

It was a positive quarter for AbbVie with growth in revenue, gross profit, and net income.